Literature DB >> 19143860

Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.

E Ioachim1.   

Abstract

Aberrations in the cell cycle regulators are common features of many tumours and several have been shown to have prognostic significant in colorectal cancer. The expression patterns of cyclins D1 and E as well as cyclin-dependent kinase (CDK) inhibitors p21waf1/cip1 and p27kip1 and their interrelationship with other cell cycle checkpoint proteins [p53, pRb, Ki-67 and proliferative cell nuclear antigen (PCNA)] were investigated in colorectal cancer in order to ascertain coregulation and influence on tumour behaviour or survival. These molecular markers were localisated immunohistochemically using the monoclonal antibodies anticyclin D1 (DCS-6), anticyclin E (13A3), anti-p21 (4D10), anti-p27 (1B4), anti-p53 (DO7), anti-Rb (AB-5), MIB1 and PC10 in colorectal cancer tissue from 97 patients. Data were analysed statistically using the spss software program. Overexpression of cyclin D1, cyclin E and p21waf1/cip1 proteins (>5% positive neoplastic cells) was observed in 5.9%, 30% and 7.2% of the cases respectively. Increased levels of cyclin D1 (p = 0.0001) and p21waf1/cip1 protein (p = 0.03) in tumours with mucous differentiation were observed. Overexpression of cyclin D1 was correlated with tumour stage (p = 0.03), the lymph node involvement (p = 0.02), as well as p21waf1/cip1 protein expression (p < 0.0001). Cyclin E was positively correlated with p21waf1/cip1 (p = 0.014), as well as with the cell proliferation as measured by PCNA-labelling index (p = 0.011) and Ki-67 score (p = 0.007). A positive relationship of p21waf1/cip1 expression with the proliferative-associated index Ki-67 was noted (p = 0.005). Downregulation of p27kip1 was observed in 47.4% of the cases and was correlated with downregulation of pRb (p = 0.002) and PCNA score (p = 0.004). The prognostic significance of cyclins D1, E and CDK inhibitors p21waf1/cip1, p27kip1 in determining the risk of recurrence and overall survival with both univariate (long-rang test) and multivariate (Cox regression) methods of analysis showed no statistically significance differences. In conclusion, these findings suggest that, the levels of the cell cycle regulators studied, do not seems to have a prognostic value, in terms of predicting the risk of early recurrence and overall survival. In addition, the interrelationships, probably means their contribution to the regulation of cell growth, through different pathways in colorectal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19143860     DOI: 10.1111/j.1742-1241.2006.01105.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  16 in total

1.  Expression and clinical role of TCTP in epithelial ovarian cancer.

Authors:  Chen Chen; Yan Deng; Minhui Hua; Qinghua Xi; Rong Liu; Shuyun Yang; Jian Liu; Jianxin Zhong; Meilan Tang; Shumin Lu; Zhimei Zhang; Xiao Min; Chunhui Tang; Yingying Wang
Journal:  J Mol Histol       Date:  2015-01-07       Impact factor: 2.611

2.  Molecular prognostic factors in rectal cancer treated by preoperative chemoradiotherapy.

Authors:  Taek-Keun Nam; Ji-Shin Lee; Hyeong-Rok Kim; Sung-Ja Ahn; Ju-Young Song; Mee Sun Yoon
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

Review 3.  DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment.

Authors:  S Solier; Y-W Zhang; A Ballestrero; Y Pommier; G Zoppoli
Journal:  Curr Cancer Drug Targets       Date:  2012-05       Impact factor: 3.428

4.  Increased cyclin T1 expression as a favorable prognostic factor in treating gastric adenocarcinoma.

Authors:  Jong-Shiaw Jin; Lien-Fu Lin; Jui-Chang Chen; Chia-Chi Huang; Jeng-Horng Sheu; Wenlung Chen; Tang-Yi Tsao; Chih-Wei Hsu
Journal:  Oncol Lett       Date:  2015-09-25       Impact factor: 2.967

5.  Expression of cyclin E in stage III colorectal carcinoma.

Authors:  Lea Rath-Wolfson; Michael Bergman; Yaacov Ori; Alex Goldman; Edward Ram; Rumelia Koren; Hertzel Salman
Journal:  Oncol Lett       Date:  2012-10-05       Impact factor: 2.967

6.  Elevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients.

Authors:  Ping Xu; Mengyang Zhao; Zhen Liu; Yiyi Liu; Yiyu Chen; Rongcheng Luo; Weiyi Fang
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

7.  Analysis of cell cycle-related proteins in gastric intramucosal differentiated-type cancers based on mucin phenotypes: a novel hypothesis of early gastric carcinogenesis based on mucin phenotype.

Authors:  Tamotsu Sugai; Mitsunori Tsukahara; Masaki Endoh; Yoshihiro Shioi; Noriko Takebe; Yoshiharu Mue; Hiroo Matsushita; Minoru Toyota; Kazuyuki Suzuki
Journal:  BMC Gastroenterol       Date:  2010-06-07       Impact factor: 3.067

8.  IgG expression in human colorectal cancer and its relationship to cancer cell behaviors.

Authors:  Na Niu; Jie Zhang; Tao Huang; Yingui Sun; Zhengshan Chen; Weining Yi; Christine Korteweg; Juping Wang; Jiang Gu
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

9.  Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer.

Authors:  M P Myklebust; Z Li; T H Tran; H Rui; E S Knudsen; H Elsaleh; Ø Fluge; B Vonen; H E Myrvold; S Leh; K M Tveit; R G Pestell; O Dahl
Journal:  Br J Cancer       Date:  2012-10-25       Impact factor: 7.640

10.  SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo.

Authors:  Jie Zhang; Baogang Zhang; Xumei Zhang; Yingui Sun; Xiaolong Wei; Michael A McNutt; Shijun Lu; Yuqing Liu; Donghong Zhang; Mingyu Wang; Zhijuan Lin; Na Niu
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.